Researchers at a Canadian hospital are suggesting that the flu vaccine is worth getting, despite the potential risk of developing Guillain-Barre Syndrome (GBS).
Guillain-Barre Syndrome is a rare condition in which the body’s immune system attacks the nervous system. GBS can start out as a tingling sensation or muscle weakness and can lead to paralysis. There is no cure for Guillain-Barre, but the side effects can be lessened with treatment.
GBS has been commonly known as a vaccine injury since 1976 when GBS diagnoses increased among people who got the flu shot to protect against the swine flu virus.
Many individuals, particularly healthcare workers, cite GBS as one of the reasons they avoid the flu vaccine, according the Washington Post. However, advocates at a hospital in Canada are suggesting that GBS flu shot fears should not be a deterrent to getting vaccinated.
Researchers at the Ottawa Hospital Research Center advise that in most cases, people are better off getting the flu vaccine. Developing GBS from a flu shot is an extremely rare occurrence.
“It is rare after the vaccine, but is scares a lot of people, and health-care workers,” said Kumanan Wilson, a professor of internal medicine at Ottawa Hospital.
The Anapol Weiss vaccine injury lawyers have advocated on behalf of numerous clients who developed GBS from a flu shot. Still, they recognize the importance of the flu vaccine in our society and urge people to follow their physician’s recommendations regarding the flu shot.